The Quality Standards Subcommittee ...

The Quality Standards Subcommittee of the American Academy of Neurology has released a strange guideline entitled, "Practice Parameter: returning Stroke with Patent Foramen Ovale and Atrial Septal Aneurysm." The guideline is available online at http://www.neurology.org/cgi/content/full/62/7/1042.

A patent foramen ovale (PFO) is a small opening between the pair upper chambers of the heart, or the atria. The opening normally bring to a periods shortly after birth, but does not end in up to 25 percent of race Current thinking is that patients with a PFO who have had a knock with no known cause and received treatment are at greater risk of having a other stroke than those patients who had a blow and did not have a PFO However, this is not real according to the guideline. Having a PFO does not place the patient at increased risk for a periodical stroke.

There has been more [i]or[/i] less debate within the medical community about whether PFO should be clos or managed with medication. According to the guideline, there is no evidence to support or disprove the role of closing a PFO for attack prevention. More research is distressed to answer this question.

individuals younger than 55 years with the two a PFO and an atrial septal aneurysm (ASA) may have an increased risk of a next to the first stroke. An ASA is a swelling in the wall between the atria and arises in an estimated 5 percent of the bulk of mankind Up to 70 percent of the bulk of mankind with an ASA also have a PFO

the couple aspirin and warfarin reduce the risk of vital current clots that can cause blow According to the guideline, there is inadequate evidence to determine whether aspirin or warfarin is the better medication to preclude subsequent stroke and death. However, the side weight of minor bleeding is more customary with warfarin than aspirin.

The authors of the guideline call for more research onward the effects of an ASA forward stroke risk and how ASAs should be managed. They also encourage physicians to communicate with patients who have had a knock and are on aspirin or warfarin therapies about their events to come health risks. Patients should know that the demeanor of a PFO does not necessarily signify an increased risk for later stroke, however these patients should consider participating in research studies to further address this condition.

COPYRIGHT 2004 American Academy of Family Physicians

COPYRIGHT 2004 Gale Group